BioCentury | Jul 22, 2013
Company News

Carbylan BioSurgery management update

Carbylan BioSurgery Inc. , Palo Alto, Calif. Business: Inflammation, Autoimmune Hired: David Renzi as president, CEO and a director, formerly president and CEO of Neomend Inc., which C.R. Bard Inc. acquired WIR Staff autoimmune Inflammation...
BioCentury | Jul 22, 2013
Company News

Carbylan BioSurgery board of directors update

Carbylan BioSurgery Inc. , Palo Alto, Calif. Business: Inflammation, Autoimmune Appointed: Samuel Lynch as chairman; Lynch founded BioMimetic Therapeutics Inc. , which Wright Medical Group Inc. acquired WIR Staff...
BioCentury | Dec 3, 2012
Company News

Carbylan BioSurgery, Shanghai Jingfeng deal

...bacterially derived hyaluronic acid (HA) chemically modified to form biodegradable hydrogel beads, and a corticosteroid. Carbylan BioSurgery Inc....
BioCentury | Aug 1, 2011
Clinical News

Hydros-TA: Phase II data

...of Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) markets Synvisc-One hylan G-F 20, a modified natural hyaluronan. Carbylan BioSurgery Inc....
Items per page:
1 - 4 of 4
BioCentury | Jul 22, 2013
Company News

Carbylan BioSurgery management update

Carbylan BioSurgery Inc. , Palo Alto, Calif. Business: Inflammation, Autoimmune Hired: David Renzi as president, CEO and a director, formerly president and CEO of Neomend Inc., which C.R. Bard Inc. acquired WIR Staff autoimmune Inflammation...
BioCentury | Jul 22, 2013
Company News

Carbylan BioSurgery board of directors update

Carbylan BioSurgery Inc. , Palo Alto, Calif. Business: Inflammation, Autoimmune Appointed: Samuel Lynch as chairman; Lynch founded BioMimetic Therapeutics Inc. , which Wright Medical Group Inc. acquired WIR Staff...
BioCentury | Dec 3, 2012
Company News

Carbylan BioSurgery, Shanghai Jingfeng deal

...bacterially derived hyaluronic acid (HA) chemically modified to form biodegradable hydrogel beads, and a corticosteroid. Carbylan BioSurgery Inc....
BioCentury | Aug 1, 2011
Clinical News

Hydros-TA: Phase II data

...of Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) markets Synvisc-One hylan G-F 20, a modified natural hyaluronan. Carbylan BioSurgery Inc....
Items per page:
1 - 4 of 4